Trending Market News
Acadia Pharmaceuticals announced that its experimental drug remlifanserin failed to meet the primary endpoint in a mid-stage trial for Alzheimer's disease psychosis, which affects approximately 30% of Alzheimer's patients. Despite missing the main goal of reducing hallucinations and delusions after six weeks, the company will continue enrolling patients in two ongoing late-stage studies while discontinuing the 30-mg dose.
- The 60-mg once-daily dose showed greater improvement than placebo but fell short of statistical significance on the primary endpoint, though improvement increased throughout the six-week period
- The drug achieved statistical significance on a key secondary measure evaluating overall severity of Alzheimer's disease psychosis symptoms
- Safety profile was favorable with side effect rates similar to placebo, no apparent adverse effects on movement or cognitive function, and no deaths reported among patients receiving the drug
Lowe's is launching a drone delivery service in partnership with DoorDash and Alphabet's Wing, becoming the first home improvement retailer to offer this technology. The service, currently piloting in Matthews, North Carolina, delivers over 100 products within 20 minutes to customers within a 5-mile radius. The initiative aims to reduce friction for shoppers who need items mid-project without leaving their home or job site.
- Drones can transport orders of approximately 2.5 pounds per flight within a 5-mile radius, with delivery windows as fast as 20 minutes for over 100 products
- Customers order through DoorDash's platform, where drone delivery appears as an option for eligible users in the pilot location
- Lowe's joins retailers like Walmart, Amazon, and Uber Eats in adopting drone delivery, though the technology faces regulatory challenges and public concerns about noise and privacy
Qualcomm announced Thursday it has extended its chip licensing agreement with Apple, effective April 1. The extension follows a 2019 settlement that ended a two-year legal battle over wireless-patent royalties and modem-chip supply. Apple exercised its option to extend the original six-year licensing deal by two years.
- The original agreement stemmed from a 2019 settlement where Apple made an undisclosed payment to Qualcomm and both companies dropped worldwide litigation
- The initial six-year global patent licensing deal ran from April 1, 2019, and included an option for Apple to extend by two years
- Neither company disclosed financial details or specific terms of the extended agreement
The US FDA approved Eli Lilly's Onswik, a once-weekly basal insulin injection for adults with type 2 diabetes, offering an alternative to daily insulin shots. The approval is based on clinical trials involving over 3,400 adults that showed the treatment effectively reduces blood sugar levels comparable to daily insulin options. The drug will be available in the US in coming months and has already received regulatory approvals in Europe, Japan, and Mexico.
- Onswik (insulin efsitora alfa-gobe) could reduce the number of injections by more than 300 per year compared to once-daily basal insulin treatments
- Late-stage trials across four studies demonstrated A1C reductions non-inferior to daily insulin glargine (sold as Sanofi's Lantus and Lilly's Basaglar)
- The drug should not be used in type 1 diabetes patients due to increased risk of severe hypoglycemia; it will be available as a pre-filled KwikPen in 500 and 1,000 units per milliliter concentrations
President Donald Trump and Chinese Leader Xi Jinping are meeting at the White House for a high-stakes summit focused on trade, artificial intelligence, Taiwan, and the Iran war. This marks Xi's first visit to Washington since 2015, with Trump making an unprecedented trip to Joint Base Andrews to personally greet Xi upon arrival. China analysts predict the summit will be cautious and yield few major deliverables despite the elaborate diplomatic ceremony.
- Trump became the first president since Obama in 2015 to greet a foreign leader at Joint Base Andrews, rolling out a red carpet and meeting Xi at the airplane stairs
- The summit agenda covers critical issues including trade tensions, AI policy, Taiwan relations, and the Iran conflict, though expectations for concrete outcomes remain modest
- A state dinner featuring U.S. business executives will be held, though Xi's planned delegation of Chinese CEOs reportedly did not materialize for the event
Merck announced that its experimental eye drug remigromig met the primary goal in a mid- to late-stage clinical trial for diabetic macular edema, a serious eye condition that can lead to blindness. The drug demonstrated non-inferiority compared to the control drug ranibizumab in adult patients with the disease, which causes swelling and fluid buildup in the retina.
- Remigromig achieved non-inferiority versus ranibizumab (the control drug) in treating diabetic macular edema
- Diabetic macular edema affects blood vessels at the back of the eye and causes swelling in the macula, potentially leading to blindness
- Trial results will be presented at the upcoming American Academy of Ophthalmology annual meeting
Bentley Motors has launched its first fully electric vehicle, the Torcal, priced at $229,500, entering the luxury EV market three months after Ferrari's controversial $626,000 Luce debut. The British carmaker's entry comes as other luxury brands like Porsche and Lamborghini scale back electric ambitions due to weak demand.
- The Torcal features a 600-kilometer range and sub-three-second 0-60mph acceleration, priced significantly lower than Ferrari's Luce at $229,500 versus $626,000
- Bentley CEO Frank-Steffen Walliser reports 'growing' acceptance of EVs among wealthy buyers despite broader market skepticism from competitors
- The vehicle represents Bentley's fourth model line and was developed over a four-year cycle at the company's Crewe, England manufacturing site
Amazon plans to invest $3 billion in India's quick commerce sector by 2030, with $1 billion by 2027 and an additional $2 billion through 2030. This marks the company's largest bet on fast-delivery services in India, where it currently holds only 6.2% market share compared to domestic rivals controlling 77%. The investment aims to help Amazon catch up in a rapidly growing sector projected to double from $19 billion to $41 billion by 2030.
- Amazon's India quick commerce business has exceeded $1 billion in annualized gross sales over the past three months, making it the fastest-growing segment in Amazon India's history
- Investment will fund expansion of small neighborhood warehouses, AI-powered demand prediction tools, and inventory management systems, with focus on daily essentials rather than one-off purchases like iPhones
- Domestic competitors Blinkit, Swiggy, and Zepto control 77% of the market with over 4,500 stores combined, while Walmart's Flipkart holds 11% with 1,000+ stores, leaving Amazon significantly behind
Swedish fashion retailer H&M reported third-quarter operating profit for June-August that exceeded market expectations. The company also provided guidance that September sales are expected to increase 1% in local currencies, signaling continued positive momentum for the retailer.
- H&M's June-August operating profit rose more than analysts had anticipated
- The company forecasts September sales growth of 1% in local currencies
- The results suggest H&M is maintaining profitability despite challenging retail market conditions
Qantas airport workers at four major Australian airports launched a 24-hour strike on Thursday, demanding higher pay, job security, and improved safety standards. The industrial action by the Transport Worker's Union involves ground services, freight operations, and regional carrier employees, with safety screeners in Sydney planning additional stoppages through September 28.
- Workers are seeking pay increases matching industry standards, more full-time positions, and consolidation under a single Qantas structure instead of fragmented subsidiaries
- The union cites safety concerns with workers being 'maimed and killed,' calling for a 'fundamental reset' after years of cost-cutting by Qantas
- Qantas was previously ordered to pay A$90 million ($64 million) after illegally outsourcing over 1,800 ground worker jobs during the COVID-19 pandemic
Chinese pharmaceutical company InnoCare Pharma announced a research collaboration and licensing agreement with U.S.-based Eli Lilly valued at up to $3.35 billion. The deal represents a significant cross-border partnership in drug development between the Chinese biotech firm and the major American pharmaceutical company.
- The agreement is structured as a research collaboration and license deal, though specific therapeutic areas or drug candidates were not disclosed in the announcement
- The total deal value of up to $3.35 billion likely includes upfront payments plus milestone-based payments contingent on development and commercial success
- This partnership reflects continued collaboration between Chinese and Western pharmaceutical companies despite broader geopolitical tensions
Honda Motor is preparing to build a new hybrid vehicle production plant in Ohio with an investment of $1.90 billion to $2.53 billion (300-400 billion yen), according to the Nikkei business daily. The plant is expected to begin production in 2030, marking a significant expansion of Honda's hybrid vehicle manufacturing capacity in the United States.
- Investment range: 300-400 billion yen ($1.90-$2.53 billion) for the new Ohio facility
- Production timeline: Plant expected to start operations in 2030
- Honda is in final preparation stages for the hybrid vehicle manufacturing facility
Boeing's hopes for securing new aircraft orders from China at the upcoming US-China summit are fading, with the company now focused on finalizing a previously announced 200-jet deal from May rather than winning additional commitments. Boeing has been effectively shut out of the Chinese market since 2017 while European rival Airbus has gained ground, despite China expecting to order 9,000 new jets by 2045.
- Boeing had initially discussed a deal for hundreds of jets ahead of the spring summit but only secured 200 aircraft in May, which remains unfinalized
- The Thursday summit agenda prioritizes extending the trade truce, AI safeguards, Taiwan arms sales, and commodity flows over new aircraft deals
- Airbus has gained market share in China through its Tianjin assembly line and more stable China-Europe relations, while Boeing faces both political headwinds and internal operational challenges
SoftBank Group has issued $11.1 billion in dollar- and euro-denominated bonds to fund its artificial intelligence investments. The proceeds will finance the final $10 billion tranche of SoftBank's $30 billion commitment to OpenAI, bringing its total investment in the ChatGPT-maker to $64.6 billion.
- The bond issuance includes $10 billion in dollar-denominated senior notes across three terms (3.5, 5.5, and 7.5 years) with interest rates ranging from 8.625% to 9.75%
- An additional €1 billion in euro-denominated notes were issued with 4-year and 6-year terms yielding 7.125% and 8% respectively
- SoftBank also issued 1 trillion yen ($6.32 billion) in corporate bonds aimed at retail investors earlier this month
The U.S. and China have extended their trade truce by two months to January 10, as Chinese President Xi Jinping began a state visit to Washington through Friday. Treasury Secretary Scott Bessent announced the extension on Fox News, noting Beijing must fulfill additional deliverables, though the extension is shorter than the six months many had anticipated.
- The original one-year trade truce agreed in South Korea last October was set to expire in November but will now run until January 10
- The two-month extension is significantly shorter than the six months or longer that many observers had expected ahead of the summit
- Treasury Secretary Bessent met with Chinese Vice Premier He Lifeng in New York prior to Xi's arrival to discuss the trade agreement terms
CEOs from major surveillance technology companies, including Flock Safety, Axon Enterprise, Motorola Solutions, and Verkada, declined to attend a Senate Judiciary Subcommittee hearing led by Chairman Josh Hawley examining AI-powered surveillance cameras and privacy concerns. The hearing addressed growing bipartisan concerns about nationwide surveillance networks, with Hawley suggesting the executives could face subpoenas to compel testimony. The scrutiny intensified after five Indiana police officers were charged with crimes related to surveillance technology misuse and a witness testified about being wrongly accused due to camera errors.
- Flock Safety operates about 120,000 AI-powered license plate readers nationwide; a single camera subscription costs approximately $3,000 annually and grants access to the entire network with billions of images
- Five Indiana police officers were charged with crimes related to misuse of surveillance technology, and witness Lindsey Isaacs testified she was wrongly accused of involvement in a fatal crash due to camera error
- Concerns about the surveillance network were bipartisan, with both Chairman Hawley and Ranking Member Durbin expressing frustration at the CEOs' absence and suggesting potential subpoenas to compel testimony
The U.S. FDA is expected to announce measures in the coming days to accelerate approval processes for vaping products and nicotine pouches, according to a Wall Street Journal report. The agency plans to revisit a 2021 rule and simplify scientific study requirements to allow more products to receive authorization. This follows pressure from tobacco companies for a faster, clearer FDA authorization process.
- The FDA may simplify requirements for scientific studies and speed up review times to add flexibility for product authorizations
- Last month, the FDA approved three new 'JUUL2' e-cigarette products as part of a series of approvals for nicotine products viewed as alternatives to traditional cigarettes
- The Trump administration emphasized commitment to keeping nicotine from children and counterfeit vaping products off streets while providing safer alternatives for adults quitting smoking
US stocks fell sharply on Wednesday as the 10-year Treasury yield surged to 5.1%, its highest level since July 2007, driven by strong economic data that increased expectations of another Federal Reserve rate hike in October. The Dow dropped 352 points (0.68%), while the S&P 500 and Nasdaq declined 0.75% and 1.13% respectively, with technology stocks leading the selloff.
- The probability of a 25-basis-point Fed rate hike in October jumped to above 66% from 55.4% a day earlier and just 8.8% a month ago, following strong September PMI data showing business activity at a five-year high.
- Oil prices surged 4.4% (Brent to $103.67) on Iran-US tensions, adding to inflation concerns and reinforcing the case for continued Fed tightening.
- Technology stocks led declines with Alphabet down 2.9%, Amazon falling 2.2%, and Nvidia dropping 1.8%, though the S&P 500's valuation fell to just under 19x forward earnings, its lowest since 2023.
A federal court hearing began Wednesday on President Trump's ban of three media outlets—MS NOW, CNN, and Politico—from the White House. Judge Timothy Kelly is considering the outlets' request to block the ban, which Trump imposed citing national security concerns, though he originally cited 'fake news' when announcing it Friday. The ban took effect Saturday with Secret Service revoking journalists' access passes.
- The Justice Department filed late Tuesday claiming Trump banned the outlets on national security grounds, a different rationale than the 'fake news' reason Trump cited when announcing the ban on Friday
- Judge Timothy Kelly, appointed by Trump in his first term, previously ruled against the White House in 2018 when he ordered restoration of CNN correspondent Jim Acosta's access pass
- The three outlets jointly filed a lawsuit on Monday after their journalists had access passes revoked by Secret Service on Saturday
The Arnault family announced plans to streamline their control of luxury conglomerate LVMH by merging their holding company Agache with Christian Dior. The restructuring, expected to complete in December, will consolidate their ownership through a single entity while maintaining their controlling stake of approximately 50% and two-thirds of voting rights in LVMH.
- Agache, which owns 96% of Christian Dior, will merge with Dior to create a new entity (also named Agache) that will directly control 49.76% of LVMH and 65.55% of voting rights
- The merger will include a tender offer for the remaining 2.44% of Christian Dior shares held by minority shareholders
- The Arnault family does not plan to delist Christian Dior following the restructuring